XASE · Laboratory Analytical Instruments · S&P 500
$7.01
+$0.10 (+1.45%) today
Open $6.91 High $7.27 Low $6.81 Vol 115K Avg $7.09
Find similar stocks by technical condition — S&P 500 universe
| Symbol | Company Name | Exchange | Currency | Category |
|---|---|---|---|---|
| STEX | Streamex Corp. Common Stock | XNAS | USD | ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS |
| NRXS | Neuraxis, Inc. | XASE | USD | ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS |
| NXL | Nexalin Technology, Inc. Common Stock | XNAS | USD | ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS |
| OM | Outset Medical, Inc. Common Stock | XNAS | USD | ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS |
| CBLL | CeriBell, Inc. Common Stock | XNAS | USD | ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS |
| QTI | QT Imaging Holdings, Inc. Common Stock | XNAS | USD | ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS |
52-week price range
Price is 219.2% above its 52-week low and 24.9% below its 52-week high. Trading in the upper half of its annual range — closer to the peak than the base.
Neuraxis Inc is a growth-stage medical technology company focused on neuromodulation therapies for chronic and debilitating conditions in the gastrointestinal (GI) digestive system, specifically from disorders of the gut-brain interaction (DGBIs) in pediatrics and adults. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).